Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00195780 · ClinicalTrials.gov registry record · Phase 3
A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents
A Phase 3 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 3
- Development phase
- 227
- Enrollment target
NCT00195780 is a Phase 3 study that has completed, run by Abbott. The registered enrollment target is 227 participants.
The verdict
NCT00195780, a Phase 3 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 227 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the long-term safety profile of the Investigational Medication Depakote ER in the treatment of Bipolar I Disorder, manic or mixed episode, in children and adolescents ages 10-17.
Interventions
- DRUG Divalproex Sodium (Depakote ER)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 227 participants |
| Start Date | 2005-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00195780
The ClinicalTrials.gov registry entry for NCT00195780 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 227 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Divalproex Sodium (Depakote ER) is the first listed.
NCT00195780 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00195780 about?
NCT00195780 is a clinical study titled "A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents". The purpose of the study is to evaluate the long-term safety profile of the Investigational Medication Depakote ER in the treatment of Bipolar I Disorder, manic or mixed episode, in children and adolescents ages 10-17.
What is the current status of trial NCT00195780?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 227 participants. The study started on 2005-02.
What interventions are being tested in trial NCT00195780?
The interventions under investigation include: Divalproex Sodium (Depakote ER) (DRUG).
Who is sponsoring clinical trial NCT00195780?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.